Recall: Anagrelide
Jun. 2022Pharmacy Updates
Teva has recalled one lot of Anagrelide 0.5 mg capsules. Anagrelide is used to treat conditions that cause a patient’s platelet count to be too high. The drug is being recalled because testing showed that it took longer than expected for the medication to dissolve in the body. Read the full text of the Anagrelide recall.
Recent Announcements
CME Webinar: Getting it Right from the Start: Identifying Patient Advanced Care Directives
Please join us for a live, CME-accredited webinar on Thursday, Oct. 15, 2026 that will educate providers on identifying advanced directives and surrogate decision makers on admission.Oct. 2026Education/Webinars
UPMC Health Plan Tapestry Link live training session
UPMC Health Plan Tapestry Link is scheduled to go live on Tuesday, Dec. 1, 2026. To help prepare you for this launch we will be hosting a live training session on Wednesday, Nov. 4, 2026, from noon to 1 p.m. to help you familiarize yourself with the platform. During this training we will discuss:Sep. 2026Education/Webinars
Clinical workflow changes through Epic®
Changes are coming for network providers that utilize Provider OnLine to submit specific information to UPMC Health Plan. Select activities that were previously completed in Provider OnLine will now transition to UPMC Health Plan Tapestry Link.Sep. 2026Important Notices